GSTC (GlobeStar Therapeutics) Receivables Turnover: 0.00 (As of Jun. 2024)


What is GlobeStar Therapeutics Receivables Turnover?

GlobeStar Therapeutics GSTC -99.00% Receivables Turnover is 0.00 as of Jun. 2024.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. GlobeStar Therapeutics's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. GlobeStar Therapeutics's average Accounts Receivable for the three months ended in Jun. 2024 was $0.00 Mil.

GlobeStar Therapeutics  (OTCPK:GSTC) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

GlobeStar Therapeutics Receivables Turnover Related Terms

GlobeStar Therapeutics Receivables Turnover Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics Receivables Turnover Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GSTC vs GBLX, ENDV, CNBX: Receivables Turnover Comparison

For the Biotechnology subindustry, GlobeStar Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlobeStar Therapeutics Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlobeStar Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where GlobeStar Therapeutics's Receivables Turnover falls into.


GlobeStar Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

GlobeStar Therapeutics's Receivables Turnover for the fiscal year that ended in Sep. 2023 is calculated as

Receivables Turnover (A: Sep. 2023 )
=Revenue / Average Accounts Receivable
=Revenue (A: Sep. 2023 ) / ((Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

GlobeStar Therapeutics's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

Receivables Turnover (Q: Jun. 2024 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jun. 2024 ) / ((Accounts Receivable (Q: Mar. 2024 ) + Accounts Receivable (Q: Jun. 2024 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
GlobeStar Therapeutics (GSTC) has a Receivables Turnover of 0.00 as of Jun. 2024. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' Receivables Turnover too high?
GlobeStar Therapeutics' current Receivables Turnover is 0.00.
How does GlobeStar Therapeutics' Receivables Turnover compare to GBLX and ENDV?
GlobeStar Therapeutics' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.29, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on GlobeStar Therapeutics and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlobeStar Therapeutics's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current Receivables Turnover is 0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.